[go: up one dir, main page]

HUP9901908A3 - P16 expression constructs and their application in cancer therapy - Google Patents

P16 expression constructs and their application in cancer therapy

Info

Publication number
HUP9901908A3
HUP9901908A3 HU9901908A HUP9901908A HUP9901908A3 HU P9901908 A3 HUP9901908 A3 HU P9901908A3 HU 9901908 A HU9901908 A HU 9901908A HU P9901908 A HUP9901908 A HU P9901908A HU P9901908 A3 HUP9901908 A3 HU P9901908A3
Authority
HU
Hungary
Prior art keywords
application
cancer therapy
expression constructs
constructs
expression
Prior art date
Application number
HU9901908A
Other languages
English (en)
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of HUP9901908A2 publication Critical patent/HUP9901908A2/hu
Publication of HUP9901908A3 publication Critical patent/HUP9901908A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU9901908A 1995-07-17 1996-07-17 P16 expression constructs and their application in cancer therapy HUP9901908A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50288195A 1995-07-17 1995-07-17

Publications (2)

Publication Number Publication Date
HUP9901908A2 HUP9901908A2 (hu) 1999-09-28
HUP9901908A3 true HUP9901908A3 (en) 2000-02-28

Family

ID=23999797

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901908A HUP9901908A3 (en) 1995-07-17 1996-07-17 P16 expression constructs and their application in cancer therapy

Country Status (15)

Country Link
US (1) US6251871B1 (hu)
EP (1) EP0839207A2 (hu)
JP (1) JPH11510380A (hu)
KR (1) KR19990029028A (hu)
CN (1) CN1203632A (hu)
AU (1) AU724324B2 (hu)
BR (1) BR9609853A (hu)
CA (1) CA2227193A1 (hu)
CZ (1) CZ15498A3 (hu)
HU (1) HUP9901908A3 (hu)
NO (1) NO980218L (hu)
NZ (1) NZ313828A (hu)
PL (1) PL324750A1 (hu)
SK (1) SK6598A3 (hu)
WO (1) WO1997003635A2 (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
US7163925B1 (en) * 1995-07-17 2007-01-16 Board Of Regents, The University Of Texas System p16 expression constructs and their application in cancer therapy
GB9519275D0 (en) 1995-09-21 1995-11-22 Univ Dundee Substances and their therapeutic use
JPH11513390A (ja) † 1995-10-06 1999-11-16 アーチ デベロップメント コーポレイション 細胞殺傷のウイルス増強のための方法および組成物
JP2001524812A (ja) * 1997-02-20 2001-12-04 ヘパヴェック アクチエンゲゼルシャフト フール ジェンセラピー アポトーシス誘導タンパク質に対するｒｂの比率の減少による悪性細胞におけるアポトーシス細胞死の誘導方法
SK122399A3 (en) 1997-03-14 2000-07-11 Unilever Nv Process for producing frozen food product containing anti-freeze peptides and a frozen food product
US6489305B1 (en) 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
KR19990086165A (ko) * 1998-05-26 1999-12-15 성재갑 Cdk４ 의 저해제인 p16의 카복시말단이 절단된 결손형cδp１６ 단백질, 그의 유전자
US6420345B1 (en) * 1999-03-01 2002-07-16 Cell Genesys, Inc. Methods and reagents for inhibiting angiogenesis
US20040266834A1 (en) * 1999-10-14 2004-12-30 Copland John A. Thiazolidinediones alone or in cabination with other therapeutic agents for cancer therapy
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
EP1365794A2 (en) * 2000-07-21 2003-12-03 Lue, Tom Prevention and treatment of sexual arousal disorders
US20040005294A1 (en) * 2002-02-25 2004-01-08 Ho-Young Lee IGFBP-3 in the diagnosis and treatment of cancer
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
CN101507822B (zh) 2003-11-24 2012-06-06 坎吉有限公司 皮肤瘢痕形成的减少
ES2403558T3 (es) 2004-08-27 2013-05-20 Cyclacel Limited Inhibidores purínicos y pirimidínicos de CDK y su uso para el tratamiento de enfermedades autoinmunitarias
US7695965B2 (en) * 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
CN103293308B (zh) * 2013-05-24 2014-11-26 尉军 一种检测肿瘤标志物p16抗原表位氨基酸序列及应用
CN104558147B (zh) * 2015-01-20 2017-11-07 刘林林 一种检测宫颈癌标志物cdkn2a抗原表位多肽及应用
CN107923916A (zh) 2015-05-14 2018-04-17 爱科谱迅病理研究公司 成纤维细胞生长因子受体2（fgfr2）蛋白质的srm/mrm测定
JP6600697B2 (ja) * 2015-05-22 2019-10-30 エクスプレッション、パソロジー、インコーポレイテッド サイクリン依存性キナーゼ阻害剤２Ａ（ｐ１６）タンパク質のためのＳＲＭ／ＭＲＭアッセイ

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273085A1 (en) 1986-12-29 1988-07-06 IntraCel Corporation A method for internalizing nucleic acids into eukaryotic cells
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US6211334B1 (en) 1992-10-16 2001-04-03 Cold Spring Harbor Cell-cycle regulatory proteins, and uses related thereto
CA2146965C (en) 1992-10-16 2003-07-29 David H. Beach Cyclin complex rearrangement and uses related thereto
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
MY119195A (en) * 1993-12-30 2005-04-30 Shell Int Research Lightweight, wide-bodied compliant tower.
AU685627B2 (en) 1994-03-18 1998-01-22 Myriad Genetics, Inc. Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
JPH08510651A (ja) 1994-03-18 1996-11-12 ミリアド・ジェネティックス・インコーポレイテッド Ｍｔｓ遺伝子、それにおける変異、およびｍｔｓ遺伝子配列を用いる癌の診断方法
US6689561B1 (en) * 1994-04-14 2004-02-10 The Regents Of The University Of California Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
AU697088B2 (en) 1994-04-29 1998-09-24 Sidney Kimmel Cancer Center Enhancing the sensitivity of tumor cells to therapies
DE19501073A1 (de) * 1995-01-16 1996-08-01 Nova C O R D Ag Bildverarbeitungsverfahren zur Ermittlung der Strukturfestigkeit eines Prüfobjektes mit diffus streuender Oberfläche
WO1996025507A2 (en) * 1995-02-17 1996-08-22 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of preparation and use of recombinant adenoviral vectors
US5672508A (en) 1996-01-23 1997-09-30 Mitotix, Inc. Inhibitors of cell-cycle progression, and uses related thereto
EP0969720B1 (en) 1997-02-18 2007-05-09 CANJI, Inc. Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms

Also Published As

Publication number Publication date
HUP9901908A2 (hu) 1999-09-28
WO1997003635A3 (en) 1997-05-15
CN1203632A (zh) 1998-12-30
CZ15498A3 (cs) 1998-07-15
BR9609853A (pt) 1999-10-13
NZ313828A (en) 1999-02-25
WO1997003635A2 (en) 1997-02-06
NO980218L (no) 1998-03-16
NO980218D0 (no) 1998-01-16
EP0839207A2 (en) 1998-05-06
US6251871B1 (en) 2001-06-26
PL324750A1 (en) 1998-06-08
JPH11510380A (ja) 1999-09-14
AU6647896A (en) 1997-02-18
KR19990029028A (ko) 1999-04-15
SK6598A3 (en) 1998-09-09
AU724324B2 (en) 2000-09-14
CA2227193A1 (en) 1997-02-06

Similar Documents

Publication Publication Date Title
HUP9901908A3 (en) P16 expression constructs and their application in cancer therapy
HU9502117D0 (en) Potentiation of temezolomide in human tumor cells
AU2603895A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
PL340604A1 (en) Application of macrolydes in treating tumours and maculopathy
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
ZA964563B (en) Isoindole derivatives their preparation and their application in therapy
GB9509572D0 (en) Cancer therapy
AU7674896A (en) Adenovirus-antisense k-ras expression vectors and their application in cancer therapy
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
GB9514816D0 (en) Substances and their medical use
AU6390596A (en) C-cam expression constructs and their application in cancer therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
AU5554598A (en) Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
AU5871898A (en) Microparticles and their use in cancer treatment
AU3361595A (en) Formulation and use of carotenoids in treatment of cancer
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis
NZ311995A (en) Chalcone retinoids and methods of use of same in cancer and precancer cells
AU3728595A (en) Antibodies against an extracellular matrix complex and their use in the detection of cancer
AU4499196A (en) Antibodies for use in cancer therapy and diagnosis
IL118542A0 (en) Isoindole derivatives their preparation and their application in therapy
GB9616504D0 (en) Therapeutic product and its use
AU4861996A (en) A proliferation-inhibiting gene sequence and its use in the treatment of cancer and other diseases
GB9621093D0 (en) Antigen for use in cancer therapy and diagnosis